Gliapharm Sa, A Biotech Company That Specializes In The Research And Development Of Novel Therapies To Treat And Prevent Neurological Diseases, And The Wyss Center, A Non-Profit Organization Dedicated To Accelerating Discoveries In Neuroscience To Improve Patient Lives, Today Announced A Collaboration To Develop New Treatments For Alzheimer'S Disease.One Of The Hallmarks Of Neurodegenerative Diseases Such As Alzheimer
